The Business Times
business-time-50

Korean biotech firm takes second shot at Singapore backdoor listing

google-preferred-sourceAdd BT as a preferred source
Published Thu, Jul 16, 2020 · 09:50 PM

Singapore

A SOUTH KOREAN steelmaker controls a firm that makes kimchi lactobacillus (lactic acid bacteria) is trying again to secure a listing for the latter biotech firm by a backdoor route.

Stainless steel manufacturer Kossen, a key shareholder of BiogenicsKorea, has signed an implementation agreement with Epicentre Holdings (the former authorised Apple retailer) and Tardis Capital, said Epicentre's judicial managers (JMs) on Wednesday.

BiotechSGXEpicentre holdings

TRENDING NOW

In 2027, the combined maximum incentives for EV cars will be lowered to S$20,000 from S$30,000 currently.

Changes to EV incentives, uncertainty over COE framework drive Category A premium to a new high in ‘re-run of 2025 mania’

In hiring for AI-fluent users, companies will do well to better define and test applicants on their capacity for human oversight.

Employers want AI-fluent employees. Hiring them is the challenge

Employees may grumble about long hours, difficult clients or demanding deadlines, but often the biggest push factor is how they are treated.

What makes a good job? Feeling that you matter

The eligible projects include Sun Group’s developments linked to the Asia-Pacific Economic Cooperation summit in Phu Quoc in 2027.

Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More